{
  "ticker": "BIIB",
  "company": "Biogen",
  "quarter": "Q3 2025",
  "date": "2025-07-28",
  "content": "Biogen Financial Overview\nData as of: 2025-07-28\n\nCompany Metrics:\nStock Price: $12.45\nMarket Cap: $35,167,003,409\n52-Week High: $16.18\n52-Week Low: $8.71\n\nValuation Metrics:\nP/E Ratio (TTM): 35.7\nForward P/E: 32.1\nPEG Ratio: 0.54\nPrice to Book: 9.6\n\nFinancial Performance:\nRevenue (TTM): $1,466,724,010\nRevenue Growth (YoY): 39.6%\nGross Margin: 54.1%\nOperating Margin: 19.9%\nNet Margin: 13.9%\n\nProfitability:\nReturn on Assets: 20.6%\nReturn on Equity: 46.9%\nProfit Margin: 13.9%\n\nTrading Information:\nBeta: 0.54\nDividend Yield: 2.47%\nPrevious Close: $12.20\nDay Range: $12.07 - $12.70\nVolume: 47,418,052\nAverage Volume: 9,811,072",
  "source": "batch-cache",
  "cached_at": "2025-07-28T21:15:02.704742"
}